Zavzpret (Zavegepant)

Zavegepant is a medicine used to treat a migraine once it starts. It is a nasal spray. It works by blocking a body chemical called CGRP that helps cause migraine pain.

Brand names:Zavzpret
Medication

What people taking Zavzpret (Zavegepant) report

Every report comes from a Lived member, sent anonymously.

Have you tried Zavzpret (Zavegepant) for Migraines?

NameHow it went

About Zavzpret (Zavegepant)

What It's For

Zavegepant, sold as Zavzpret, is a prescription nasal spray used to treat a migraine attack in adults once it has started, whether or not the attack comes with aura (temporary visual or sensory changes before or during the headache). It does not prevent migraines, so it is not a substitute for a daily or monthly preventive treatment. It belongs to a newer group of migraine medicines called gepants, which block the receptor for CGRP (calcitonin gene-related peptide), a signaling protein involved in migraine. Other gepants, such as Nurtec ODT (rimegepant) and Ubrelvy (ubrogepant), are taken by mouth. Zavegepant is the only one given as a nasal spray, which can make it an option when nausea or vomiting makes swallowing a tablet hard. Gepants are also an alternative for people who cannot take or do not get enough relief from triptans, the older migraine-specific pills and sprays.

How It Works

During a migraine attack, nerves around the head release CGRP. CGRP widens blood vessels and promotes inflammation around those nerves, and both are thought to feed the pain of an attack. Zavegepant blocks the receptor that CGRP acts on, which is thought to dampen this process. Because it is sprayed into the nose, the medicine is absorbed quickly, reaching its highest level in the blood about 30 minutes after a dose. How blocking CGRP translates into relief is not fully understood, and it does not work for every attack or every person.

Dosage & Administration

Zavzpret comes as a single-use device that holds one dose: one spray (10 mg) into one nostril, taken when a migraine starts. Do not use more than one dose in 24 hours. The safety of treating more than eight migraines in a 30-day period has not been established. Before using it, blow your nose gently. Keep the device in its sealed package until you are ready, and do not test or prime it, because pressing the plunger releases the only dose. Close the other nostril, keep your head upright rather than tilted back, and breathe in gently through your nose as you press the plunger. Afterward, keep your head level and breathe in through your nose for 10 to 20 seconds; if it drips, sniff gently so the dose is not lost.

Side Effects

The most common side effect is a change in taste, often a bitter or unpleasant taste or a reduced sense of taste, which affected about 18% of people in clinical trials compared with 4% on placebo. Nausea, nose discomfort and vomiting are less common. These effects are usually short-lived after a dose. Serious allergic reactions, including anaphylaxis, have occurred, though rarely. Swelling of the face, lips or throat or trouble breathing after a dose needs emergency care (call 911). Hives or a rash should be reported to the prescriber right away, and the spray should not be used again until it has been discussed. Anyone who has had an allergic reaction to zavegepant should not use it.

Interactions & Warnings

Medicines in the CGRP-blocking family have been linked to new high blood pressure or worsening of existing high blood pressure, sometimes needing treatment or a hospital stay. It was most often reported in the first week after starting. People with high blood pressure, or risk factors for it, may want to check readings after starting and should tell the prescriber if they rise. These medicines have also been linked to Raynaud's phenomenon, where fingers or toes turn white or blue and become cold, numb or painful, usually within a couple of days of a dose. If this happens, stop the spray and contact the prescriber; in most reported cases it improved after stopping. People who already have Raynaud's should discuss this risk first. Nasal decongestant sprays can reduce how much zavegepant is absorbed. They are best avoided, and if one is needed, use it at least 1 hour after zavegepant. Some medicines change how the body clears zavegepant, including rifampin (an antibiotic used mainly for tuberculosis), so the prescriber and pharmacist should review all prescriptions, over-the-counter medicines and supplements. Zavegepant should be avoided by people with severe liver disease or severe kidney disease. There is little information on its use in pregnancy or breastfeeding, so anyone pregnant, planning pregnancy or nursing should talk this through with the prescriber.

What to Expect

In the two main trials, people treated a moderate or severe migraine with one spray. Two hours later, about 23% were completely pain free compared with about 15% on placebo, and about 59% had their pain reduced to mild or none compared with about 50% on placebo. It also helped more people be free of their most bothersome symptom, such as sensitivity to light or sound, or nausea. In other words, it helps some attacks substantially, helps others partly, and some attacks will need another plan. It is usually worth trying on more than one attack before judging whether it works for you. Keeping a simple record of when you used it, how fast it helped and any side effects makes that conversation easier. Comparisons with oral gepants come only from indirect analyses and have not shown a clear advantage in longer-lasting relief. If attacks are frequent, or acute treatment is needed on many days a month, a preventive treatment may be worth discussing.

Questions to Ask Your Doctor

  1. 1.Why might a nasal spray suit my attacks better than a gepant tablet or a triptan?
  2. 2.What should I do if one spray does not relieve my migraine, and what can I take afterward?
  3. 3.Do I need to check my blood pressure after starting, and how often?
  4. 4.Could any of my current medicines, nasal sprays or supplements affect how zavegepant works?
  5. 5.How many migraines a month would make a preventive treatment worth considering?

Last reviewed • Oct 2026

Educational content, not medical advice.